ALLURION TECHNOLOGIES INC (ALUR) is a publicly traded Healthcare sector company. As of May 21, 2026, ALUR trades at $0.67 with a market cap of $0 and a P/E ratio of -0.06. ALUR moved -6.79% today. Year to date, ALUR is -68.70%; over the trailing twelve months it is -84.16%. Its 52-week range spans $0.32 to $25.00. Analyst consensus is buy with an average price target of $5.50. Rallies surfaces ALUR's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Allurion Exercises 2.66M Warrants at $1.15 to Raise $3M: Allurion Technologies will immediately exercise 2.66 million warrants at $1.15 per share, raising $3 million with closing expected on Feb. 25. It plans to register up to 5.32 million shares underlying new warrants and has filed a premarket approval application with U.S. regulators for its Allurion Gastric Balloon System.
| Metric | Value |
|---|---|
| Price | $0.67 |
| Market Cap | $0 |
| P/E Ratio | -0.06 |
| EPS | $-11.64 |
| Dividend Yield | 0.00% |
| 52-Week High | $25.00 |
| 52-Week Low | $0.32 |
| Volume | 236.46K |
| Avg Volume | 0 |
| Revenue (TTM) | $32.11M |
| Net Income | $-26.15M |
| Gross Margin | 66.97% |
2 analysts cover ALUR: 0 strong buy, 2 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.50.